Teleflex Inc financial data

Symbol
TFX on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
550 E Swedesford Rd, Suite 400, Wayne, PA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 275 % +11.2%
Quick Ratio 108 % +7.04%
Debt-to-equity 68.1 % -1.78%
Return On Assets 3.52 % -34.3%
Operating Margin 12 % -33.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.1M shares +0.27%
Entity Public Float 5.63B USD -19.4%
Common Stock, Value, Issued 48M USD +0.19%
Weighted Average Number of Shares Outstanding, Basic 47.2M shares +0.36%
Weighted Average Number of Shares Outstanding, Diluted 47.4M shares +0.07%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.01B USD +3.76%
Research and Development Expense 152M USD -5.96%
Operating Income (Loss) 360M USD -30.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 281M USD -37.9%
Income Tax Expense (Benefit) 16.5M USD -80.4%
Net Income (Loss) Attributable to Parent 264M USD -28.5%
Earnings Per Share, Basic 5.6 USD/shares -28.6%
Earnings Per Share, Diluted 5.57 USD/shares -28.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 239M USD -4.88%
Accounts Receivable, after Allowance for Credit Loss, Current 449M USD +4.56%
Inventory, Net 637M USD +0.85%
Assets, Current 1.44B USD -0.53%
Deferred Income Tax Assets, Net 6.42M USD +2.33%
Property, Plant and Equipment, Net 492M USD +5.9%
Operating Lease, Right-of-Use Asset 112M USD -9.09%
Intangible Assets, Net (Excluding Goodwill) 2.38B USD +6.82%
Goodwill 2.89B USD +13.6%
Other Assets, Noncurrent 121M USD +47.5%
Assets 7.44B USD +7.92%
Accounts Payable, Current 113M USD -20.2%
Employee-related Liabilities, Current 113M USD +6.53%
Accrued Liabilities, Current 153M USD +20%
Liabilities, Current 557M USD +0.23%
Deferred Income Tax Liabilities, Net 453M USD +17.6%
Operating Lease, Liability, Noncurrent 103M USD -8.61%
Other Liabilities, Noncurrent 120M USD +0.09%
Liabilities 2.88B USD +7.55%
Accumulated Other Comprehensive Income (Loss), Net of Tax -314M USD +22.1%
Retained Earnings (Accumulated Deficit) 4.11B USD +7.66%
Stockholders' Equity Attributable to Parent 4.56B USD +8.15%
Liabilities and Equity 7.44B USD +7.92%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Financing Activities -71.4M USD +23.7%
Net Cash Provided by (Used in) Investing Activities -24.8M USD -13.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 48M shares +0.19%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 239M USD -4.88%
Deferred Tax Assets, Valuation Allowance 95.7M USD +4.61%
Operating Lease, Liability 131M USD -6.5%
Depreciation 15.9M USD -12.9%
Payments to Acquire Property, Plant, and Equipment 38.4M USD +76%
Lessee, Operating Lease, Liability, to be Paid 153M USD -8.42%
Property, Plant and Equipment, Gross 1.05B USD +4.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.6M USD +5.22%
Lessee, Operating Lease, Liability, to be Paid, Year One 24M USD -2.66%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -58.3M USD -2886%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.9M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21.7M USD +9.09%
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 2.02M USD -52.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 20.3M USD +5.68%
Additional Paid in Capital 750M USD +4.84%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 50.1M USD +20.6%
Deferred Tax Assets, Net of Valuation Allowance 154M USD +9.18%
Interest Expense 92.8M USD +35.5%